HAP Trading’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-16,100
Closed -$1K 2246
2020
Q4
$1K Sell
16,100
-400
-2% -$2.59K ﹤0.01% 2155
2020
Q3
$25K Buy
16,500
+1,300
+9% +$6.17K ﹤0.01% 1123
2020
Q2
$23K Sell
15,200
-3,300
-18% -$11.2K ﹤0.01% 1272
2020
Q1
$46K Buy
+18,500
New +$79.8K ﹤0.01% 789
2019
Q3
Sell
-25,900
Closed -$8K 1347
2019
Q2
$8K Buy
25,900
+2,600
+11% +$14K ﹤0.01% 990
2019
Q1
$19K Buy
+23,300
New +$162K ﹤0.01% 844
2016
Q4
Sell
-13,218
Closed -$6K 1168
2016
Q3
$6K Buy
+13,218
New +$350K ﹤0.01% 1028

Other funds holding PGEN

HAP Trading's PGEN Position: Q3 2019 in Review

HAP Trading sold out of Precigen (PGEN) in Q3 2019, closing a stake of 74,440 shares — an estimated $570K sold.

HAP Trading first reported a position in PGEN in Q4 2018 and held it in 3 quarters. The position peaked at $800K in Q4 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • HAP Trading reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • HAP Trading sold 74,440 Precigen shares in Q3 2019, an estimated $570K.
  • HAP Trading first reported a position in Precigen in Q4 2018 and held it in 3 quarters.
  • HAP Trading's Precigen position peaked at $800K in Q4 2018.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on HAP Trading's 13F filing for Q3 2019, filed 12 Nov 2019.